IMMUNOGLOBULIN G

IMMUNOGLOBULIN G was reported 56774 times

IMMUNOGLOBULIN G is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOMEGALOVIRUS MYELOMENINGORADICULITIS 1 0.1429
1 PALATOPLASTY 1 0.1111
2 AIRWAY SECRETION CLEARANCE THERAPY 1 0.0667
3 ALLERGY TO IMMUNOGLOBULIN THERAPY 6 0.0550
4 ANAL BLISTER 1 0.0250
5 INSTILLATION SITE PARAESTHESIA 1 0.0238
6 TREPONEMA TEST POSITIVE 1 0.0192
7 PORCELAIN GALLBLADDER 1 0.0189
8 ARTERIOVENOUS GRAFT SITE INFECTION 1 0.0179
9 JOINT MICROHAEMORRHAGE 1 0.0143
10 SINUS PERFORATION 1 0.0135
11 ALLERGY TO VACCINE 4 0.0129
12 PRIMARY IMMUNODEFICIENCY SYNDROME 1 0.0123
13 PNEUMONECTOMY 2 0.0114
14 SELECTIVE IGG SUBCLASS DEFICIENCY 1 0.0106
15 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
16 TRACHEOSTOMY INFECTION 1 0.0082
17 HEPATITIS B CORE ANTIBODY POSITIVE 3 0.0080
18 ENCEPHALITIS CYTOMEGALOVIRUS 3 0.0068
19 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 1 0.0068
20 BLOOD IMMUNOGLOBULIN E DECREASED 1 0.0062
21 SCABIES 1 0.0058
22 SOCIOECONOMIC PRECARITY 1 0.0058
23 PERIPARTUM CARDIOMYOPATHY 1 0.0058
24 INFUSION SITE DISCHARGE 10 0.0057
25 ORAL BLOOD BLISTER 1 0.0050
26 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0047
27 SHUNT INFECTION 1 0.0044
28 PALATAL SWELLING 1 0.0041
29 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
30 SUPERFICIAL VEIN PROMINENCE 1 0.0039
31 VAGINAL CYST 1 0.0037
32 CATHETER SITE THROMBOSIS 1 0.0036
33 CREUTZFELDT-JAKOB DISEASE 1 0.0035
34 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
35 ASPIRATION BRONCHIAL 1 0.0034
36 HYPERINSULINAEMIA 1 0.0033
37 CHORIORETINITIS 2 0.0031
38 INFUSION SITE HAEMORRHAGE 10 0.0030
39 INFUSION SITE URTICARIA 2 0.0030
40 ADMINISTRATION SITE BRUISE 1 0.0029
41 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
42 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
43 ALTERNARIA INFECTION 1 0.0027
44 PITYRIASIS ROSEA 1 0.0027
45 PORPHYRIA 1 0.0026
46 JC VIRUS INFECTION 4 0.0025
47 DEPENDENCE ON RESPIRATOR 1 0.0025
48 DEATH OF RELATIVE 1 0.0025
49 RETICULOCYTE COUNT DECREASED 1 0.0023
50 INFUSION SITE BRUISING 5 0.0023
51 BIOPSY BONE MARROW ABNORMAL 1 0.0022
52 ALLERGY TO ARTHROPOD STING 1 0.0022
53 CIRRHOSIS ALCOHOLIC 1 0.0022
54 METAPLASIA 1 0.0021
55 HEPATIC HAEMATOMA 1 0.0021
56 INFUSION SITE ABSCESS 1 0.0020
57 CERVICAL INCOMPETENCE 1 0.0020
58 INJECTION SITE NECROSIS 4 0.0020
59 BLOOD PRESSURE IMMEASURABLE 3 0.0020
60 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
61 SINUSITIS BACTERIAL 2 0.0019
62 INFUSION SITE CELLULITIS 1 0.0019
63 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
64 GRIEF REACTION 1 0.0019
65 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
66 INFUSION SITE MASS 2 0.0018
67 BACTERIURIA 1 0.0018
68 GROIN ABSCESS 2 0.0017
69 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
70 URETHRAL HAEMORRHAGE 1 0.0017
71 HYPERACUSIS 6 0.0016
72 PERNICIOUS ANAEMIA 1 0.0016
73 SPIDER VEIN 1 0.0016
74 MENINGITIS ASEPTIC 7 0.0016
75 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
76 PNEUMOCOCCAL SEPSIS 1 0.0015
77 ABSCESS NECK 1 0.0015
78 INFUSION SITE INFLAMMATION 1 0.0014
79 FACIAL DISCOMFORT 1 0.0014
80 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
81 PROTEUS INFECTION 1 0.0014
82 PALMOPLANTAR KERATODERMA 1 0.0014
83 LOCAL REACTION 1 0.0013
84 RESPIRATORY TRACT OEDEMA 1 0.0013
85 MYASTHENIC SYNDROME 1 0.0013
86 INFUSION SITE SWELLING 8 0.0013
87 CROUP INFECTIOUS 1 0.0013
88 DEVICE DAMAGE 1 0.0013
89 TOTAL LUNG CAPACITY DECREASED 2 0.0013
90 PULSE ABNORMAL 3 0.0012
91 PANCREATITIS RELAPSING 1 0.0012
92 DYSBIOSIS 1 0.0012
93 INJECTION SITE ATROPHY 2 0.0012
94 FUNGAL SEPSIS 1 0.0012
95 COVID-19 IMMUNISATION 1 0.0012
96 OESOPHAGEAL RUPTURE 1 0.0012
97 PARONYCHIA 5 0.0011
98 INFUSION SITE DISCOLOURATION 1 0.0011
99 OROPHARYNGEAL CANDIDIASIS 1 0.0011
100 ABDOMINAL RIGIDITY 3 0.0011
101 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
102 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
103 VENOUS INJURY 1 0.0011
104 BONE CYST 1 0.0011
105 ARNOLD-CHIARI MALFORMATION 1 0.0010
106 NEUTROPENIC INFECTION 1 0.0010
107 INFUSION SITE NODULE 1 0.0010
108 DUST ALLERGY 1 0.0010
109 INFUSION SITE REACTION 3 0.0010
110 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
111 EYE COLOUR CHANGE 1 0.0010
112 BONE MARROW OEDEMA 1 0.0010
113 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
114 INFUSION SITE PRURITUS 3 0.0009
115 POLYOMAVIRUS VIRAEMIA 1 0.0009
116 NEUROMYOPATHY 1 0.0009
117 ALLERGY TO ANIMAL 1 0.0009
118 INNER EAR DISORDER 1 0.0009
119 UTERINE PROLAPSE 1 0.0009
120 PRODUCT NAME CONFUSION 1 0.0009
121 PRODUCT LEAKAGE 5 0.0009
122 BENIGN NEOPLASM 1 0.0009
123 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
124 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
125 INFECTION REACTIVATION 1 0.0009
126 ADMINISTRATION SITE PAIN 1 0.0009
127 PAROTITIS 1 0.0009
128 BLADDER OPERATION 1 0.0009
129 PRURITUS ALLERGIC 1 0.0009
130 PNEUMONIA INFLUENZAL 1 0.0008
131 SECONDARY IMMUNODEFICIENCY 1 0.0008
132 INFUSION SITE WARMTH 1 0.0008
133 DEVICE INFUSION ISSUE 2 0.0008
134 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
135 HEPATIC INFECTION 1 0.0008
136 HERPES OPHTHALMIC 1 0.0008
137 ABDOMINAL MASS 2 0.0007
138 IMMUNOGLOBULINS DECREASED 1 0.0007
139 CHRONIC FATIGUE SYNDROME 1 0.0007
140 PHARYNGEAL SWELLING 7 0.0007
141 PERIODONTAL DISEASE 1 0.0007
142 ENDOTRACHEAL INTUBATION 2 0.0007
143 NAIL INFECTION 1 0.0007
144 INVESTIGATION ABNORMAL 1 0.0007
145 MYASTHENIA GRAVIS CRISIS 1 0.0007
146 INFUSION SITE INDURATION 1 0.0007
147 CENTRAL VENOUS CATHETERISATION 2 0.0007
148 RUBBER SENSITIVITY 1 0.0007
149 INFUSION SITE PAIN 8 0.0006
150 INJECTION SITE INFECTION 2 0.0006
151 LIGAMENT SPRAIN 6 0.0006
152 QUADRIPARESIS 1 0.0006
153 VEIN RUPTURE 1 0.0006
154 INSURANCE ISSUE 9 0.0006
155 SKIN WOUND 1 0.0006
156 ACUTE SINUSITIS 1 0.0006
157 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
158 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
159 PANCREATIC FAILURE 1 0.0006
160 INJECTION SITE DISCHARGE 3 0.0006
161 PNEUMOMEDIASTINUM 1 0.0006
162 ASTHMATIC CRISIS 2 0.0005
163 LYMPH NODE PAIN 1 0.0005
164 MECHANICAL VENTILATION 1 0.0005
165 DERMATITIS CONTACT 6 0.0005
166 PARANASAL SINUS HYPERSECRETION 2 0.0005
167 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
168 ARTERIAL DISORDER 1 0.0005
169 HYPOREFLEXIA 1 0.0005
170 EXERCISE TOLERANCE DECREASED 3 0.0005
171 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
172 DERMATITIS PSORIASIFORM 1 0.0005
173 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
174 SKIN INDURATION 1 0.0005
175 INSULIN RESISTANCE 1 0.0005
176 PETECHIAE 5 0.0005
177 INFUSION SITE ERYTHEMA 4 0.0005
178 RENAL PAIN 5 0.0005
179 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
180 LIMB MASS 1 0.0005
181 NOSOCOMIAL INFECTION 1 0.0005
182 INFUSION SITE INFECTION 1 0.0004
183 UMBILICAL HERNIA 2 0.0004
184 PLATELET DISORDER 1 0.0004
185 DRUG RESISTANCE 10 0.0004
186 FOOD ALLERGY 3 0.0004
187 MENOPAUSE 1 0.0004
188 BRAIN FOG 6 0.0004
189 RADICULOPATHY 1 0.0004
190 WHITE BLOOD CELL DISORDER 1 0.0004
191 CLUMSINESS 1 0.0004
192 BLOOD PHOSPHORUS INCREASED 1 0.0004
193 PHOTOSENSITIVITY REACTION 6 0.0004
194 CYTOMEGALOVIRUS INFECTION 6 0.0004
195 OXYGEN SATURATION ABNORMAL 1 0.0004
196 MUSCULOSKELETAL DISCOMFORT 6 0.0003
197 ADENOVIRUS INFECTION 1 0.0003
198 DEVICE POWER SOURCE ISSUE 1 0.0003
199 NECK INJURY 1 0.0003
200 ATYPICAL PNEUMONIA 1 0.0003
201 VARICES OESOPHAGEAL 1 0.0003
202 PRODUCT DISTRIBUTION ISSUE 3 0.0003
203 BLOOD BLISTER 1 0.0003
204 POLYMYALGIA RHEUMATICA 1 0.0003
205 AUTOIMMUNE DISORDER 3 0.0003
206 HYPOGAMMAGLOBULINAEMIA 2 0.0003
207 EAR INFECTION 8 0.0003
208 SKIN MASS 2 0.0003
209 BRONCHIECTASIS 2 0.0003
210 HYPOPNOEA 1 0.0003
211 AORTIC STENOSIS 1 0.0003
212 RIGHT VENTRICULAR FAILURE 2 0.0003
213 EAR PRURITUS 1 0.0003
214 CONJUNCTIVAL HYPERAEMIA 1 0.0003
215 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
216 MIDDLE INSOMNIA 5 0.0003
217 AUTOIMMUNE THYROIDITIS 1 0.0003
218 CATHETER SITE INFECTION 1 0.0003
219 PARANASAL SINUS DISCOMFORT 1 0.0003
220 LOSS OF CONTROL OF LEGS 1 0.0003
221 CLAVICLE FRACTURE 1 0.0003
222 THYROID MASS 1 0.0003
223 OESOPHAGEAL ULCER 1 0.0003
224 REHABILITATION THERAPY 1 0.0003
225 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
226 VIRAL LOAD INCREASED 1 0.0003
227 VASCULITIS 3 0.0003
228 RHINOVIRUS INFECTION 1 0.0003
229 INFUSION RELATED REACTION 17 0.0003
230 ORAL INFECTION 1 0.0003
231 POLYDIPSIA 1 0.0003
232 BLOOD ALBUMIN DECREASED 2 0.0003
233 LOW BIRTH WEIGHT BABY 2 0.0003
234 SKIN PAPILLOMA 1 0.0002
235 BLEPHARITIS 1 0.0002
236 CYSTITIS HAEMORRHAGIC 1 0.0002
237 SPINAL FUSION SURGERY 1 0.0002
238 PERIPHERAL VENOUS DISEASE 1 0.0002
239 EXTRAVASATION 1 0.0002
240 ANAPHYLACTOID REACTION 1 0.0002
241 HEPATIC PAIN 1 0.0002
242 POOR QUALITY SLEEP 5 0.0002
243 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
244 PULMONARY FUNCTION TEST DECREASED 1 0.0002
245 IMMUNE SYSTEM DISORDER 3 0.0002
246 CATHETERISATION CARDIAC 1 0.0002
247 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
248 SINUSITIS 23 0.0002
249 SKIN LESION 6 0.0002
250 EAR DISORDER 1 0.0002
251 IMMUNE THROMBOCYTOPENIA 1 0.0002
252 PNEUMONIA BACTERIAL 2 0.0002
253 EYE OPERATION 1 0.0002
254 CHRONIC MYELOID LEUKAEMIA 1 0.0002
255 LOCALISED OEDEMA 1 0.0002
256 YELLOW SKIN 1 0.0002
257 FLANK PAIN 2 0.0002
258 SKIN TIGHTNESS 1 0.0002
259 VAGINAL INFECTION 1 0.0002
260 SEASONAL ALLERGY 3 0.0002
261 LIP SWELLING 7 0.0002
262 HYPOKINESIA 3 0.0002
263 PANCREATIC DISORDER 1 0.0002
264 BREATH SOUNDS ABNORMAL 1 0.0002
265 INJECTION SITE INFLAMMATION 1 0.0002
266 KLEBSIELLA INFECTION 1 0.0002
267 DYSPHORIA 1 0.0002
268 INCREASED UPPER AIRWAY SECRETION 1 0.0002
269 VARICOSE VEIN 1 0.0002
270 POOR VENOUS ACCESS 2 0.0002
271 INJECTION SITE DISCOMFORT 2 0.0002
272 ANORECTAL DISCOMFORT 1 0.0002
273 HEREDITARY ANGIOEDEMA 2 0.0002
274 ANAL ABSCESS 1 0.0002
275 BEHAVIOUR DISORDER 1 0.0002
276 TOOTH FRACTURE 2 0.0002
277 HYPERKERATOSIS 1 0.0002
278 VIRAL INFECTION 6 0.0002
279 PROCEDURAL PAIN 5 0.0002
280 TRANSAMINASES INCREASED 4 0.0002
281 STREPTOCOCCAL INFECTION 1 0.0002
282 FEELING COLD 5 0.0002
283 HEART RATE ABNORMAL 1 0.0002
284 ANGIOPATHY 1 0.0002
285 NEPHROPATHY TOXIC 2 0.0002
286 CANDIDA INFECTION 3 0.0002
287 EYE INFECTION 2 0.0002
288 PREMATURE LABOUR 1 0.0002
289 BRONCHITIS 13 0.0002
290 NEOPLASM 2 0.0002
291 HYPOVOLAEMIA 1 0.0002
292 PLEURISY 1 0.0002
293 HEPATITIS B 1 0.0002
294 PLATELET COUNT ABNORMAL 1 0.0002
295 MENISCUS INJURY 1 0.0002
296 OLIGURIA 1 0.0002
297 INFUSION SITE EXTRAVASATION 1 0.0002
298 SWOLLEN TONGUE 5 0.0002
299 SWELLING OF EYELID 1 0.0002
300 FEELING JITTERY 3 0.0002
301 THROAT IRRITATION 7 0.0002
302 PROCTALGIA 1 0.0002
303 HIATUS HERNIA 2 0.0002
304 SWELLING FACE 10 0.0002
305 RESPIRATORY TRACT INFECTION 4 0.0002
306 ORAL CANDIDIASIS 2 0.0002
307 STAPHYLOCOCCAL INFECTION 5 0.0002
308 SINUS DISORDER 3 0.0002
309 ASTHMA 17 0.0002
310 MENINGITIS 1 0.0001
311 POST-TRAUMATIC STRESS DISORDER 1 0.0001
312 WRONG PRODUCT ADMINISTERED 1 0.0001
313 THROAT TIGHTNESS 4 0.0001
314 ILLNESS 15 0.0001
315 ANAPHYLACTIC REACTION 8 0.0001
316 NECK PAIN 8 0.0001
317 LYMPHADENOPATHY 5 0.0001
318 NEEDLE ISSUE 4 0.0001
319 COVID-19 24 0.0001
320 BLINDNESS TRANSIENT 1 0.0001
321 SENSITIVE SKIN 1 0.0001
322 MEDICAL DEVICE COMPLICATION 1 0.0001
323 HYDRONEPHROSIS 1 0.0001
324 DYSARTHRIA 5 0.0001
325 TENDON PAIN 1 0.0001
326 VERTIGO 8 0.0001
327 DRUG DISPENSING ERROR 2 0.0001
328 EPILEPSY 4 0.0001
329 PELVIC FRACTURE 1 0.0001
330 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
331 AFFECTIVE DISORDER 1 0.0001
332 CYANOSIS 2 0.0001
333 FURUNCLE 1 0.0001
334 INFLUENZA 14 0.0001
335 ABSCESS 2 0.0001
336 SENSORY LOSS 1 0.0001
337 RHINITIS 1 0.0001
338 MYASTHENIA GRAVIS 1 0.0001
339 FRUSTRATION TOLERANCE DECREASED 1 0.0001
340 DECUBITUS ULCER 1 0.0001
341 INJECTION SITE URTICARIA 3 0.0001
342 POLYURIA 1 0.0001
343 ESCHERICHIA INFECTION 1 0.0001
344 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
345 SPINAL COMPRESSION FRACTURE 1 0.0001
346 FUNGAL INFECTION 4 0.0001
347 BLOOD UREA INCREASED 2 0.0001
348 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
349 SCAR 2 0.0001
350 PSEUDOMONAS INFECTION 1 0.0001
351 HAEMATOMA 3 0.0001
352 ECZEMA 6 0.0001
353 URINE OUTPUT DECREASED 1 0.0001
354 OROPHARYNGEAL DISCOMFORT 1 0.0001
355 LIMB INJURY 3 0.0001
356 IRON DEFICIENCY ANAEMIA 1 0.0001
357 FLUSHING 11 0.0001
358 AGRANULOCYTOSIS 2 0.0001
359 PHOTOPHOBIA 2 0.0001
360 PRODUCT PACKAGING ISSUE 1 0.0001
361 HAEMATOTOXICITY 1 0.0001
362 MIGRAINE 10 0.0001
363 INCREASED APPETITE 2 0.0001
364 HYPERSOMNIA 3 0.0001
365 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
366 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
367 CONTUSION 10 0.0001
368 INFECTION 15 0.0001
369 THERAPY CHANGE 1 0.0001
370 INABILITY TO AFFORD MEDICATION 1 0.0001
371 BLOOD PRESSURE ABNORMAL 2 0.0001
372 APHASIA 3 0.0001
373 DRUG LEVEL DECREASED 1 0.0001
374 MOTOR DYSFUNCTION 1 0.0001
375 INJECTION SITE RASH 3 0.0001
376 OROPHARYNGEAL PAIN 9 0.0001
377 EYE DISCHARGE 1 0.0001
378 TENDERNESS 1 0.0001
379 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
380 JOINT DISLOCATION 1 0.0001
381 FULL BLOOD COUNT ABNORMAL 1 0.0001
382 CYSTITIS 3 0.0001
383 JOINT INJURY 2 0.0001
384 PHARYNGITIS STREPTOCOCCAL 1 0.0001
385 SKIN LACERATION 1 0.0001
386 PULMONARY THROMBOSIS 1 0.0001
387 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
388 OESOPHAGITIS 1 0.0001
389 ANGIOEDEMA 4 0.0001
390 NERVE INJURY 1 0.0001
391 OCULAR DISCOMFORT 1 0.0001
392 ARTHRITIS 7 0.0001
393 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
394 STATUS EPILEPTICUS 1 0.0001
395 REBOUND EFFECT 1 0.0001
396 MYOCARDITIS 1 0.0001
397 CAESAREAN SECTION 1 0.0001
398 PRODUCT DOSE OMISSION ISSUE 25 0.0001
399 BLOOD IRON DECREASED 1 0.0001
400 BACTERAEMIA 1 0.0001
401 MYOCLONUS 1 0.0001
402 ACCIDENT 1 0.0001
403 WRIST FRACTURE 1 0.0001
404 BLOOD PRESSURE FLUCTUATION 2 0.0001
405 BURSITIS 1 0.0001
406 ADRENAL INSUFFICIENCY 1 0.0001
407 CYTOPENIA 1 0.0001
408 SMALL INTESTINAL OBSTRUCTION 1 0.0001
409 SPINAL OPERATION 1 0.0001
410 INJECTION SITE MASS 3 0.0001
411 GENERALISED OEDEMA 1 0.0001
412 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
413 CYST 1 0.0001
414 INJECTION SITE DISCOLOURATION 1 0.0001
415 MUSCULOSKELETAL STIFFNESS 7 0.0001
416 DERMATITIS ALLERGIC 1 0.0001
417 EXPOSURE VIA SKIN CONTACT 2 0.0001
418 PLATELET COUNT INCREASED 1 0.0001
419 NODULE 1 0.0001
420 TOOTH INFECTION 1 0.0001
421 PULMONARY CONGESTION 1 0.0001
422 TACHYPNOEA 1 0.0001
423 PALLOR 2 0.0001
424 PERIPHERAL COLDNESS 1 0.0001
425 APPLICATION SITE RASH 1 0.0001
426 MEDICATION ERROR 4 0.0001
427 ORAL DISCOMFORT 1 0.0001
428 APHONIA 1 0.0001
429 MASS 1 0.0001
430 BLOOD TEST ABNORMAL 1 0.0001
431 SKIN EXFOLIATION 6 0.0001
432 IMPAIRED QUALITY OF LIFE 1 0.0001
433 BALANCE DISORDER 6 0.0001
434 PARAESTHESIA ORAL 1 0.0001
435 MYELODYSPLASTIC SYNDROME 1 0.0001
436 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
437 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
438 LIVER DISORDER 3 0.0001
439 ABDOMINAL DISTENSION 7 0.0001
440 HAEMORRHAGE 7 0.0001
441 DEVICE ISSUE 6 0.0001
442 RESPIRATORY DISORDER 2 0.0001
443 THERAPY NON-RESPONDER 3 0.0001
444 PREMATURE BABY 2 0.0001
445 HYPOAESTHESIA ORAL 1 0.0001
446 HEPATIC FAILURE 2 0.0001
447 LACRIMATION INCREASED 2 0.0001
448 OSTEOPENIA 1 0.0001
449 DISCOMFORT 4 0.0001
450 BLOOD PRESSURE INCREASED 10 0.0001
451 INJECTION SITE SWELLING 5 0.0001
452 PHARYNGEAL OEDEMA 1 0.0001
453 DEVICE RELATED INFECTION 1 0.0001
454 THYROID DISORDER 1 0.0001
455 LYMPHOMA 1 0.0001
456 SWELLING 6 0.0001
457 BASAL CELL CARCINOMA 1 0.0001
458 HEADACHE 40 0.0001
459 PRODUCT USE COMPLAINT 1 0.0001
460 PNEUMOTHORAX 1 0.0001
461 PRODUCTIVE COUGH 3 0.0001
462 OBESITY 1 0.0001
463 SCIATICA 1 0.0001
464 SENSORY DISTURBANCE 1 0.0001
465 MUSCLE TIGHTNESS 1 0.0001
466 BACK DISORDER 1 0.0001
467 VENTRICULAR TACHYCARDIA 1 0.0001
468 COAGULOPATHY 1 0.0001
469 URINARY RETENTION 2 0.0001
470 CELLULITIS 3 0.0001
471 FACE OEDEMA 1 0.0001
472 PNEUMONIA 19 0.0001
473 HEPATIC ENZYME INCREASED 4 0.0001
474 URINARY TRACT INFECTION 10 0.0001
475 CHEST DISCOMFORT 6 0.0001
476 PRODUCT USE ISSUE 11 0.0001
477 PERIPHERAL SWELLING 9 0.0001
478 INFLAMMATION 3 0.0001
479 DEVICE DEFECTIVE 1 0.0001
480 PRURITUS 22 0.0001
481 BURNING SENSATION 4 0.0001
482 COLD SWEAT 1 0.0001
483 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
484 HEAD DISCOMFORT 1 0.0001
485 ISCHAEMIC STROKE 1 0.0001
486 GASTROINTESTINAL DISORDER 5 0.0001
487 GASTROENTERITIS VIRAL 1 0.0001
488 RESTLESS LEGS SYNDROME 1 0.0001
489 PYREXIA 19 0.0001
490 END STAGE RENAL DISEASE 1 0.0001
491 CONJUNCTIVITIS 1 0.0001
492 EYE SWELLING 2 0.0001
493 THINKING ABNORMAL 1 0.0001
494 BACTERIAL INFECTION 1 0.0001
495 BLOOD SODIUM DECREASED 1 0.0001
496 BLOOD URINE PRESENT 1 0.0001
497 SLEEP APNOEA SYNDROME 1 0.0001
498 ACUTE RESPIRATORY FAILURE 1 0.0001
499 GLAUCOMA 1 0.0001
500 PRESCRIBED OVERDOSE 1 0.0001
501 EAR PAIN 1 0.0001
502 ORAL HERPES 1 0.0001
503 SURGERY 3 0.0001
504 KIDNEY INFECTION 1 0.0001
505 DISABILITY 1 0.0001
506 CATARACT 3 0.0001
507 PREGNANCY 1 0.0000
508 BONE MARROW FAILURE 1 0.0000
509 INJURY ASSOCIATED WITH DEVICE 1 0.0000
510 PRODUCT PREPARATION ERROR 1 0.0000
511 INJECTION SITE ERYTHEMA 6 0.0000
512 URTICARIA 8 0.0000
513 DERMATITIS 1 0.0000
514 OSTEOARTHRITIS 2 0.0000
515 EATING DISORDER 1 0.0000
516 IRRITABLE BOWEL SYNDROME 1 0.0000
517 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
518 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
519 FAECES DISCOLOURED 1 0.0000
520 SEPTIC SHOCK 2 0.0000
521 PRODUCT DISPENSING ERROR 1 0.0000
522 PRODUCT PRESCRIBING ISSUE 1 0.0000
523 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
524 SEPSIS 5 0.0000
525 INJECTION SITE PRURITUS 3 0.0000
526 RASH PAPULAR 1 0.0000
527 SNEEZING 1 0.0000
528 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
529 PRODUCT QUALITY ISSUE 6 0.0000
530 APPLICATION SITE PRURITUS 1 0.0000
531 PRODUCT AVAILABILITY ISSUE 1 0.0000
532 SKIN IRRITATION 2 0.0000
533 RASH 19 0.0000
534 TINNITUS 2 0.0000
535 SKIN DISCOLOURATION 2 0.0000
536 CONFUSIONAL STATE 7 0.0000
537 HYPERSENSITIVITY 8 0.0000
538 INJECTION SITE PAIN 13 0.0000
539 THERAPY INTERRUPTED 3 0.0000
540 DRUG INTOLERANCE 4 0.0000
541 LOCALISED INFECTION 1 0.0000
542 INTERSTITIAL LUNG DISEASE 2 0.0000
543 FIBROMYALGIA 1 0.0000
544 ENCEPHALOPATHY 1 0.0000
545 WEIGHT INCREASED 9 0.0000
546 AGEUSIA 1 0.0000
547 INCORRECT DOSE ADMINISTERED 9 0.0000
548 NAUSEA 31 0.0000
549 HYPOPHAGIA 1 0.0000
550 HOSPITALISATION 6 0.0000
551 ERECTILE DYSFUNCTION 1 0.0000
552 UNRESPONSIVE TO STIMULI 1 0.0000
553 JOINT STIFFNESS 1 0.0000
554 GASTRITIS 1 0.0000
555 NASOPHARYNGITIS 7 0.0000
556 BRADYCARDIA 2 0.0000
557 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
558 FEAR 1 0.0000
559 FREQUENT BOWEL MOVEMENTS 1 0.0000
560 GAIT DISTURBANCE 7 0.0000
561 INFLUENZA LIKE ILLNESS 3 0.0000
562 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
563 RESPIRATORY DISTRESS 1 0.0000
564 WEIGHT DECREASED 10 0.0000
565 PANCYTOPENIA 2 0.0000
566 COUGH 10 0.0000
567 BLISTER 2 0.0000
568 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
569 PAIN IN JAW 1 0.0000
570 INTENTIONAL DOSE OMISSION 1 0.0000
571 RED BLOOD CELL COUNT DECREASED 1 0.0000
572 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
573 SEIZURE 4 0.0000
574 MALAISE 15 0.0000
575 PAIN 21 0.0000
576 CHILLS 4 0.0000
577 DIZZINESS 17 0.0000
578 ERYTHEMA 7 0.0000
579 PSYCHOTIC DISORDER 1 0.0000
580 INSOMNIA 9 0.0000
581 TACHYCARDIA 3 0.0000
582 WHEEZING 2 0.0000
583 RENAL INJURY 1 0.0000
584 FATIGUE 26 0.0000
585 JOINT SWELLING 4 0.0000
586 FALL 11 0.0000
587 EMOTIONAL DISORDER 1 0.0000
588 LIMB DISCOMFORT 1 0.0000
589 FEMUR FRACTURE 1 0.0000
590 EXPOSURE DURING PREGNANCY 2 0.0000
591 PARAESTHESIA 5 0.0000
592 PULMONARY EMBOLISM 3 0.0000
593 HYPOTHYROIDISM 1 0.0000
594 NIGHT SWEATS 1 0.0000
595 DEEP VEIN THROMBOSIS 2 0.0000
596 CHOLELITHIASIS 1 0.0000
597 IMPAIRED HEALING 1 0.0000
598 HEART RATE INCREASED 3 0.0000
599 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
600 ABDOMINAL PAIN 7 0.0000
601 DYSPNOEA 17 0.0000
602 SYNCOPE 3 0.0000
603 SKIN DISORDER 1 0.0000
604 GAIT INABILITY 1 0.0000
605 TYPE 2 DIABETES MELLITUS 1 0.0000
606 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
607 FEELING ABNORMAL 7 0.0000
608 VISION BLURRED 4 0.0000
609 INJECTION SITE REACTION 2 0.0000
610 RASH MACULAR 1 0.0000
611 MOBILITY DECREASED 2 0.0000
612 MYELOSUPPRESSION 1 0.0000
613 DRUG EFFECT INCOMPLETE 1 0.0000
614 C-REACTIVE PROTEIN INCREASED 1 0.0000
615 CHEST PAIN 5 0.0000
616 DYSGEUSIA 2 0.0000
617 DYSPNOEA EXERTIONAL 1 0.0000
618 INTESTINAL OBSTRUCTION 1 0.0000
619 MUSCULAR WEAKNESS 3 0.0000
620 CHRONIC KIDNEY DISEASE 2 0.0000
621 BACK PAIN 6 0.0000
622 PLASMA CELL MYELOMA 1 0.0000
623 ALOPECIA 5 0.0000
624 INJECTION SITE BRUISING 2 0.0000
625 ABORTION SPONTANEOUS 1 0.0000
626 HYPOTENSION 5 0.0000
627 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
628 DRY MOUTH 2 0.0000
629 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
630 TREATMENT FAILURE 2 0.0000
631 ARTHRALGIA 10 0.0000
632 RHABDOMYOLYSIS 1 0.0000
633 POLLAKIURIA 1 0.0000
634 ASTHENIA 9 0.0000
635 CARDIO-RESPIRATORY ARREST 1 0.0000
636 ROAD TRAFFIC ACCIDENT 1 0.0000
637 RENAL IMPAIRMENT 2 0.0000
638 HYPERHIDROSIS 3 0.0000
639 HYPOACUSIS 1 0.0000
640 VAGINAL HAEMORRHAGE 1 0.0000
641 DEVICE DISLOCATION 1 0.0000
642 MENTAL DISORDER 1 0.0000
643 DEHYDRATION 3 0.0000
644 NEUTROPENIA 3 0.0000
645 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
646 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
647 DECREASED APPETITE 5 0.0000
648 BLOOD CHOLESTEROL INCREASED 1 0.0000
649 COGNITIVE DISORDER 1 0.0000
650 BLOOD GLUCOSE INCREASED 4 0.0000
651 DYSPHAGIA 2 0.0000
652 COMA 1 0.0000
653 ANAEMIA 4 0.0000
654 BLOOD GLUCOSE DECREASED 1 0.0000
655 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
656 ATRIAL FIBRILLATION 2 0.0000
657 LUNG DISORDER 1 0.0000
658 HYPOAESTHESIA 3 0.0000
659 LEUKOPENIA 1 0.0000
660 FLUID RETENTION 1 0.0000
661 THERAPY CESSATION 1 0.0000
662 HAEMOGLOBIN DECREASED 2 0.0000
663 ABDOMINAL PAIN UPPER 4 0.0000
664 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
665 VOMITING 9 0.0000
666 NERVOUSNESS 1 0.0000
667 PANCREATITIS 1 0.0000
668 HYPERTENSION 4 0.0000
669 RASH PRURITIC 1 0.0000
670 OEDEMA 1 0.0000
671 TREATMENT NONCOMPLIANCE 1 0.0000
672 TREMOR 3 0.0000
673 ABDOMINAL DISCOMFORT 3 0.0000
674 CEREBROVASCULAR ACCIDENT 3 0.0000
675 ANXIETY 5 0.0000
676 OFF LABEL USE 15 0.0000
677 DYSPHONIA 1 0.0000
678 PALPITATIONS 2 0.0000
679 PAIN IN EXTREMITY 5 0.0000
680 THERAPEUTIC RESPONSE DECREASED 1 0.0000
681 ILL-DEFINED DISORDER 1 0.0000
682 PLEURAL EFFUSION 1 0.0000
683 OEDEMA PERIPHERAL 2 0.0000
684 MUSCLE SPASMS 3 0.0000
685 DIARRHOEA 10 0.0000
686 AMNESIA 1 0.0000
687 BLOOD CREATININE INCREASED 1 0.0000
688 DEVICE DIFFICULT TO USE 1 0.0000
689 BLOOD PRESSURE DECREASED 1 0.0000
690 SOMNOLENCE 3 0.0000
691 MEMORY IMPAIRMENT 2 0.0000
692 SLEEP DISORDER 1 0.0000
693 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
694 SKIN BURNING SENSATION 1 0.0000
695 RESPIRATORY FAILURE 1 0.0000
696 AGITATION 1 0.0000
697 HALLUCINATION 1 0.0000
698 HOT FLUSH 1 0.0000
699 UNEVALUABLE EVENT 1 0.0000
700 DEPRESSION 3 0.0000
701 CONDITION AGGRAVATED 4 0.0000
702 DIABETES MELLITUS 1 0.0000
703 ACUTE KIDNEY INJURY 2 0.0000
704 DRUG ABUSE 1 0.0000
705 PRODUCT STORAGE ERROR 1 0.0000
706 DRUG WITHDRAWAL SYNDROME 1 0.0000
707 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
708 NO ADVERSE EVENT 2 0.0000
709 ADVERSE EVENT 1 0.0000
710 BREAST CANCER 1 0.0000
711 CARDIAC DISORDER 1 0.0000
712 NEUROPATHY PERIPHERAL 1 0.0000
713 DYSPEPSIA 1 0.0000
714 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
715 DRUG INEFFECTIVE 12 0.0000
716 RHEUMATOID ARTHRITIS 1 0.0000
717 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
718 EMOTIONAL DISTRESS 1 0.0000
719 VISUAL IMPAIRMENT 1 0.0000
720 LOSS OF CONSCIOUSNESS 1 0.0000
721 PSORIASIS 1 0.0000
722 DRUG INTERACTION 1 0.0000
723 DRUG DEPENDENCE 1 0.0000
724 DEATH 5 0.0000
725 MYOCARDIAL INFARCTION 1 0.0000